TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

The U.S. Food and Drug Administration (FDA) has announced that Risk Evaluation and Mitigation Strategies (REMS) will no longer be required for BCMA- and CD19-directed autologous CAR T cell...

In the next installment of ASTCT's Titans of Transplant series, Dr. Shernan Holtan sits down with Dr. Daniel Weisdorf—renowned leader, mentor and pioneer in cellular therapy and...

A new blog post from Jayne Kramer spotlights ASTCT’s upgraded Practice Guidelines mobile app — now featuring a modern interface, enhanced diagnostic tools and improved navigation.

In this month's President’s Message, Dr. David Porter shares his perspective on the recent dismissal of the CDC’s vaccine advisory committee—and why it matters.

An expert panel highlights key presentations in multiplemyeloma, lymphoma, and other hematologic malignancies at the 2025 ASCO Annual Meeting. CancerNetwork®, in collaboration with The...

In this episode of ASTCT Talks, Dr. Taha Al-Juhaishi welcomes Dr. Marcos de Lima, hematologist-oncologist at The Ohio State University Comprehensive Cancer Center, to explore the rapidly evolving...